Phase II Study of Oxaliplatin, Fluorouracil, and Folinic Acid in Locally Advanced or Metastatic Gastric Cancer Patients

This publication has 35 references indexed in Scilit:

• Results of a randomised trial comparing ECF with MCF in advanced oesophago-gastric cancer
  European Journal Of Cancer, 1999
• Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)
  European Journal Of Cancer, 1999
• Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)
  European Journal Of Cancer, 1998
• A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer
  Anti-Cancer Drugs, 1997
• Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
  Annals of Oncology, 1996
• Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
  Annals of Oncology, 1996
• Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial
  JNCI Journal of the National Cancer Institute, 1994
• Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
  European Journal Of Cancer, 1993
• Chemotherapy of carcinoma of the stomach
  Cancer Treatment Reviews, 1993
• A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
  Cancer, 1992